BALICH-WONDER-STUDIO
29.12.2021 14:05:13 CET | Business Wire | Press release
A new magical experience has just lit up in the middle of the desert. People could live a unique emotion by attending the Candlelight Concert , an atmospheric musical performance set in the archaeological site of Hegra (AlUla, Saudi Arabia) , the UNESCO World Heritage Site famous for having more than 100 monumental tombs carved from rock formations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211229005155/en/
The archaeological site, just 22 minutes far from the city of AlUla, has never been used for concerts of such intimate character.
The first concert that took place on the 24th December 2021 and the next one that will take place on the 31st December 2021 are produced by Balich Wonder Studio , the live entertainment group, leader in the creation and production of large-scale ceremonies, events and shows, brand and territorial experiences worldwide.
The audience live a full emotional experience by listening to the evocative repertoire performed live by the Stefan Lombard ensemble (piano, violin, cello and oud ). The famous South African musical Director has created a suite (a collection of short musical pieces) from classic compositions to contemporary, Arab, movie soundtracks and a revised take on pop music .
More than 500 high-tech candles are the magic surrounding of these musical performances: sculpted by hand, they allow spectacular graphic patterns that emotionally enhance the special moments by blending harmoniously with the forms of the archaeological site, creating a landmark that merges the suggestions of the past and the dynamic of the contemporary .
The events exploit the latest technologies as the candles thanks to their various control possibilities, can shine all night, cozily shaping the surrounding and could reach four times the brightness of a traditional candle without burning or melting: the unique color combination allows for the same warmth as a real flame candle . In addition, its innovative algorithm can make an entire set of candles flicker differently, just like real candles would.
These two special events are exclusive occasions within the suggestive AlUla Moments Season, specifically designed for ‘Winter At Tantora’. The whole season is filled with high-end cultural, musical, wellness and arts events, as well as star-studded concerts, adventurous activities and immersive heritage experiences . BWS-KSA, the branch of the Balich Wonder Studio group based in Saudi Arabia, has been appointed by the Royal Commission for AlUla to produce multiple activities throughout the entire season that will enfold in late March.
The area and the city of AlJadidah has become an exclusive gathering spot, divided in various hubs where different cultures from all over the world, itinerant performing artists and the best of the circus arts will mix and mingle in the spirit of nomadic culture and the traditional Saudi Arabian hospitality with the aim to attract the widest audience and be inclusive.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211229005155/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 13:33:00 CEST | Press release
Dr. Tracy Laabs named Director; Prof. Dr. Erwin Böttinger honored for his transformative leadership The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simult
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 13:24:00 CEST | Press release
Nearly two-thirds of patients aged 80+ treated with BRUKINSA remained progression-free at six years, despite advanced age and high-risk featuresNew European patient research reveals safety, disease severity, and effectiveness are the top drivers for first-line CLL treatment decisions – not time on therapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D.,
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 13:00:00 CEST | Press release
Once-daily oral zasocitinib demonstrated statistical superiority over deucravacitinib for all primary and key secondary endpoints in plaque psoriasis study More than 35% of zasocitinib-treated patients achieved complete skin clearance (PASI 100) at week 16 – more than 2.5 times the response rate for deucravacitinib Safety profile was consistent with previous studies with no new safety signals identified Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrate
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 13:00:00 CEST | Press release
Transaction adds 31 CLOs and more than $5 billion of AUM, strengthening Clearlake Credit’s position in liquid credit Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 12:30:00 CEST | Press release
Partnership brings together LTTS’ expertise in its Sustainability segment and the Databricks platform to accelerate Engineering Intelligence across industrial operations. L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom